Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2018

Feb 14, 2019

SELL
$31.54 - $46.67 $214,503 - $317,402
-6,801 Closed
0 $0
Q3 2018

Nov 14, 2018

BUY
$38.0 - $51.1 $38 - $51
1 Added 0.01%
6,801 $258,000
Q2 2018

Aug 14, 2018

BUY
$38.7 - $50.15 $263,160 - $341,020
6,800 New
6,800 $307,000

Others Institutions Holding GBT

About Global Blood Therapeutics, Inc.


  • Ticker GBT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,476,200
  • Market Cap $4.62B
  • Description
  • Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...
More about GBT
Track This Portfolio

Track Blue Crest Capital Management LTD Portfolio

Follow Blue Crest Capital Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Blue Crest Capital Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Blue Crest Capital Management LTD with notifications on news.